ALung Technologies, Inc. is proud to be a part of LivaNova. ALung developed the Hemolung for treating patients with acute respiratory failure. The Hemolung provides a simple, less invasive form of extracorporeal CO2 removal. By removing carbon dioxide and delivering oxygen directly to the blood, the Hemolung allows the patient’s lungs to rest and heal.